oncology

Home » shop » oncology

Oncology is a branch of medicine that deals with the prevention, diagnosis and treatment of cancer.
A medical professional who practices oncology is an oncologist.

The three components which have improved survival in cancer are:

Prevention – This is by reduction of risk factors like tobacco and alcohol consumption
Early diagnosis – Screening of common cancers and comprehensive diagnosis and staging
Treatment – Multimodality management by discussion in tumor board and treatment in a comprehensive cancer centre
Cancers are often managed through discussion on multi-disciplinary cancer conferences where medical oncologist,
surgical oncologist, radiation oncologist, pathologist, radiologist and organ specific oncologists meet to find the best
possible management for an individual patient considering the physical, social, psychological, emotional and financial status
of the patients. It is very important for oncologists to keep updated of the latest advancements in oncology, as changes in management of cancer are quite common. All eligible patients in whom cancer progresses and for whom no

standard of care treatment options are available should be enrolled in a clinical trial.

oncology products list

  • apalunix
    Product Description: BML is Lunching Apalunix 60 mg tablet which is an androgen receptor inhibitor indicated for the treatment of patients with
    • Metastatic castration-sensitive prostate cancer
    • Non-metastatic castration resistant prostate cancer.
    Apalunix  works by blocking the effects of androgen (a male reproductive hormone) to stop the growth and spread of cancer cells. Product Features:
    Product Name Apalunix
    Generic Name Apalutamide INN
    Formulation Tablet
    Available Pack Size 120's pot
    Available Strength 60 mg
    Registrations Available
    Website Apalunix.com
       
  • Product Description: Ribociclib 200 mg (Ribotix) is a CDK4/6 inhibitor that is indicated for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer. Ribociclib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of Cancer cells. Product Features:
    Product Name Ribotix
    Generic Name Ribociclib
    Formulation Tablet
    Available Pack Size 63's pot
    Available Strength 200 mg
    Registrations Available
       
  • Product Description: Pembroxim, is found in injection form, under the generic of Pembrolizumab, to help patients fighting against the infection of certain types of cancer in the world. The medicine will be used in cancer immunotherapy that includes melanoma, head and neck cancer, Hodgkin lymphoma and stomach cancer. It is suggested for slow injection into vein of the patients. Product Features:
    Product Name Pembroxim
    Generic Name Pembrolizumab
    Formulation Injection
    Available Pack Size 1's Vial
    Available Strength 100 mg/4ml
    Registrations Available
       
  • nindanix 150 nindanix 100
    Product Description: Nindanix is indicated for the treatment of locally advanced, metastatic or locally recurrent non-small cell lung cancer (NSCLC) adenocarcinoma type in combination with docetaxel for the treatment of adult patients after the failure of first-line chemotherapy. Product Features:
    Product Name Nindanix
    Generic Name Nintedanib
    Formulation Capsule
    Available Pack Size 80 & 50 Capsule
    Available Strength 100 mg, 150 mg
    Registrations Available
       
  • Product Description: Niraparix is a once-daily, oral medicine used for the maintenance treatment of women with recurrent ovarian, fallopian tube, or primary peritoneal cancer when their cancer comes back. Niraparix is the first and only once-daily PARP inhibitor used after the cancer has responded (complete or partial response) to treatment with platinum-based chemotherapy Product Features:
    Product Name Niraparix
    Generic Name Niraparib
    Formulation Capsule
    Available Strength 100 mg
    Registrations Available
       
  • Product Description: Alectinib is a kinase inhibitor indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to Crizotinib. Alectinib as monotherapy is indicated for the first-line treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC). Product Features:
    Product Name Alecinix
    Generic Name Alectinib
    Formulation Capsule
    Available Strength 150 mg
    Registrations Available
    Website alecinix.com
       
  • nilonix 200 nilonix 150
    Product Description: Nilotinib (Nilonix) is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Nilotinib is used to treat a type of blood cancer called Philadelphia chromosome positive chronic myeloid leukemia (CML) in adults and children who are at least 1 year old. Nilotinib is usually given after other medications have been tried without success. Product Features:
    Product Name Nilonix
    Generic Name Nilotinib
    Formulation Capsule
    Available Pack Size 120  Capsule
    Available Strength 150 mg, 200 mg
    Registrations Available
    Website: nilonix.com
       
  • briganix 180 briganix-90
    Product Description: BRIGANIX is indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib. This indication is approved under accelerated approval based on tumor response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial. Product Features:
    Product Name Briganix
    Generic Name Brigatinib
    Formulation Tablet
    Available Pack Size 30’s Pot
    Available Strength 90 mg, 180 mg
    Registrations Available
    Website: Briganix.com
       
  • Ribociclib
    Product Description: Ribociclib 200 mg  (Ribotix)  is a CDK4/6 inhibitor that is indicated for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer. Ribociclib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of Cancer cells. Product Features:
    Product Name Ribotix
    Generic Name Ribociclib
    Formulation Tablet
    Available Pack Size 63’s Pot
    Available Strength 200 mg
    Registrations Available
       
  • Enzalutamide enzalunix
    Product Description: Enzalutamide (Enzalunix)  a non-steroidal anti-androgen medication that is used in the treatment of prostate cancer. Enzalunix is a hormonal therapy which is indicated for metastatic castration-sensitive prostate cancer (mCSPC), metastatic castration-resistant prostate cancer (mCRPC) and non-metastatic castration-resistant prostate cancer (nmCRPC). Product Features:
    Product Name Enzalunix
    Generic Name Enzalutamide
    Formulation Tablet
    Available Pack Size 120’s Pot
    Available Strength 40 mg
    Registrations Available
       
  • Product Description: Ponatinix, is an oral drug under the generic of Ponatinib, for the first-line therapy of the people affected with chronic myelogenous leukemia. It is a highly potential and multi-targeted third generation Bcr-Abl tyrosine-kinase inhibitors (TKI) which is indicated for the adult patients with chronic phase, accelerated phase or blast phase chronic myeloid leukemia (CML) or Ph+ALL for those who have no other TKI therapy. It is also indicated for the adult patients with T315I-positive CML (chronic phase, accelerated phase of blast phase) or T315I-positive Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL). Product Features:
    Product Name : Ponatinix
    Generic Name : Ponatinib
    Formulation : Tablet
    Available Pack Size : 60’s pot
    Available Strength : 15 mg, 45 mg
    Registrations Available
    Website : Ponatinix.com
       
  • Product Description: Olaparix, is tablet and capsule forms, in treating the people suffering from ovarian and breast cancer. Olaparib is a poly (ADP-ribose) polymerase (PARP) inhibitor that is primarily indicated in treating ovarian and breast cancer. Product Features:
    Product Name : Olaparix
    Generic Name : Olaparib
    Formulation : Tablet
    Available Pack Size : 120s  pot
    Available Strength : 150 mg
    Registrations : Export Only
    Website : Olaparix.com
       
  • Product Description: Beacon Medicare Limited (BML) has launched new anti-cancer drugs in injection form under the brand name “Nivolunix,”.The medicine under the generic of Nivolumab INN is expected to accelerate cancer immunotherapy and will also be used in treating melanoma, lung, head and neck cancer, Hodgkin lymphoma and Hepatocellular carcinoma (HCC). It is suggested for slow injection into vein of the patients suffering from such type of cancer only for export purpose. Product Features:
    Product Name : Nivolunix
    Generic Name : Nivolumab
    Formulation : Injection
    Available Pack Size : 1’s Vial
    Available Strength : 100mg/10ml
    Registrations Available
       
  • Product Description: First new frontline treatment option for HCC approved in Japan Lenvatinib is amultikinase inhibitor that interrupts the pathways of VEGFR1,VEGFR2 and VEGFR3.It is used in the treatment of differentiated thyroid cancer (DTC),renal Cell Carcinoma and Hepatocellular Carcinoma (HCC) Product Features:
    Product Name : Lenvanix
    Generic Name : Lenvatinib
    Formulation : Capsule
    Available Pack Size : 30's Pot
    Available Strength :  4 mg and 10 mg
    Registrations Available
    Website : Lenvanix.com
       
  • (Osimertinib)Tagrix Osimertinib (Tagrix) is the 1st and only drug of its kind approved by USFDA for the treatment of epidermal growth factor receptor (EGFR) positive Non- Small Cell Lung Cancer (NSCLC) patient with T790M mutation. Therapeutic indications TAGRIX is indicated for the treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC). Product Name        : Tagrix Generic Name        : Osimertinib Formulation         : Tablet Available Pack size : 30’s Strengths           : 40mg & 80mg Website : www.tagrix.net
  • Product Description: Pazonix is a multiple Tyrosine Kinase Inhibitor (TKI) and it is indicated for the treatment of Renal Cell Carcinoma (RCC) effectively. Product Features:
    Product Name : Pazonix
    Generic Name : Pazopanib
    Formulation : Tablet
    Available Pack Size : 30s pot
    Available Strength : 200mg
    Registrations : Avaiable
    Website : Pazonix.com
       
  • Product Description: Ibrutix (Ibrutinib) is a kinase inhibitor indicated for the treatment of patients with: Mantle Cell Lymphoma (MCL) who have received at least one prior therapy, Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL), Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) with 17p deletion, Waldenström’s Macroglobulinemia (WM), Marginal Zone Lymphoma (MZL) who require systemic therapy and have received at least one prior anti-CD20-based therapy. Ibrutix is available in capsule form for oral administration. Capsules should be taken orally with a glass of water. Do not open, break, or chew the capsules.

    Product Features:

    Product Name : Ibrutix
    Generic Name : Ibrutinib INN
    Formulation : Capsule
    Available Pack Size : 120’s in a bottle
    Available Strength : 140 mg
    Registrations : Avaiable
    Website : www.ibrutix.com
  • afanix 40 afanix

    Product Description: Afatinib is a kinase inhibitor indicated for the First-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test & treatment of patients with metastatic, squamous NSCLC progressing after platinum-based chemotherapy. Afanix is available in tablet form for oral administration. The recommended dose of Afatinib is 40 mg orally, once daily until disease progression or no longer tolerated by the patient.

    Product Features:

    Product Name : Afanix
    Generic Name : Afatinib Dimaleate INN
    Formulation : Tablet
    Available Pack Size : 30's (3x10’s)
    Available Strengths : 40 mg
    Registrations : Available
    Website : www.afanix.com
  • Product Description: DASANIX (Dasatinib) is a kinase inhibitor. Dasatinib is a white to off-white powder.

    Product Features:

    Product Name : Dasanix
    Generic Name : Dasatinib
    Formulation : Tablet
    Available Pack Size : 3x10’s
    Available Strengths : 20 mg
    Registrations : Available
    Website : www.dasanix.com
  • Product Description: DASANIX (Dasatinib) is a kinase inhibitor. Dasatinib is a white to off-white powder.

    Product Features:

    Product Name : Dasanix
    Generic Name : Dasatinib
    Formulation : Tablet
    Available Pack Size : 6x10’s
    Available Strengths : 50 mg
    Registrations : Available
    Website : www.dasanix.com
  • Product Description: DASANIX (Dasatinib) is a kinase inhibitor. Dasatinib is a white to off-white powder.

    Product Features:

    Product Name : Dasanix
    Generic Name : Dasatinib
    Formulation : Tablet
    Available Pack Size : 3x10’s
    Available Strengths : 100 mg
    Registrations : Bangladesh
    Website : www.dasanix.com
  • Product Description:

    Regorafenib  is an oral multi-kinase inhibitor  involved in normal cellular functioning and in pathological processes such as oncogenesis, tumor angiogenesis, metastasis, and tumor immunity.It is used in the therapy of metastatic colorectal cancer , gastrointestinal stromal tumor and  hepatocellular carcinoma (HCC) who have been previously treated with Sorafenib. Product Features:
    Product Name : Regonix
    Generic Name :Regorafenib
    Formulation : Tablet
    Available size : 28’s
    Strengths : 40mg
    Registrations : Available
    Website : www.regonix.com
    Categories: Anti-Cancer
  • Product Description: Crizotinib is a kinase inhibitor indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive or ROS 1 positive. Crizotinib is the first FDA-approved biomarker-driven therapy for both ALK positive and ROS1-positive metastatic NSCLC. It is the only FDA approved drug for ROS 1 positive NSCLC.

    Indication: CRIZONIX i is indicated for the first-line treatment of adults with ALK-positive advanced NSCLC and for the treatment of adults with previously treated ALK-positive advanced NSCLC  & ROS1 (+) NSCLC. Crizotinib is an ALK and ROS1 (c-ros oncogene 1, receptor tyrosine kinase) inhibitor.

    Product Name : Crizonix
    Generic Name : Crizotinib
    Formulation : Capsule
    Available size : 28’s
    Strengths : 250mg
    Categories: Oncology
  • Product Description: Ifosfamide Injection, single use vials for administration by intravenous infusion each contain 1 gram or 3 grams of sterile Ifosfamide, USP.

    Product Features:

     
    Product Name : Xifos 1
    Generic Name : Ifosfamide
    Formulation : Lyophilized Powder for Injection
    Available Pack Size : 1’s
    Available Strengths : 1 gm & 2 gm
    Registrations : Bangladesh